Unicycive Therapeutics In...

AI Score

XX

Unlock

0.55
0.00 (0.73%)
At close: Apr 02, 2025, 3:59 PM
0.56
1.02%
After-hours: Apr 02, 2025, 07:58 PM EDT

Unicycive Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Cash & Equivalents 26.14M 9.7M 455K 16.58M n/a 15K 25K
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets n/a n/a -174K -333K 200K n/a n/a
Receivables n/a n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 4.81M 325K 159K 126K 204K 4K n/a
Total Current Assets 30.95M 13.4M 2.64M 18.41M 204K 19K 29K
Property-Plant & Equipment 720K 792K 174K 333K n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 720K 792K 174K 333K 200K n/a n/a
Total Assets 31.67M 14.19M 2.82M 18.74M 204K 19K 29K
Account Payables 1.06M 821K 846K 713K 184K 322K 60K
Deferred Revenue n/a -18K n/a n/a n/a n/a 1.00
Short-Term Debt 564K 18K 155K 151K 2.51M 460K 1.05M
Other Current Liabilities 22.5M 13.12M -109K -122K n/a n/a n/a
Total Current Liabilities 24.12M 17.53M 3.28M 2.1M 2.88M 903K 1.24M
Long-Term Debt 117K n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities 117K 466K 1.05K 155K n/a n/a n/a
Total Liabilities 24.24M 18M 3.28M 2.26M 2.88M 903K 1.24M
Total Debt 681K 811K 155K 306K 2.51M 460K 1.05M
Common Stock 114K 35K 15K 15K 9K 8K 34K
Retained Earnings -101.27M -64.54M -34M -15.94M -5.92M -3.66M -1.49M
Comprehensive Income n/a n/a n/a n/a n/a n/a 0.00
Shareholders Equity 7.43M -3.81M -466K 16.48M -2.67M -884K -1.21M
Total Investments n/a n/a n/a n/a n/a n/a n/a